Chinese General Practice ›› 2024, Vol. 27 ›› Issue (06): 637-642.DOI: 10.12114/j.issn.1007-9572.2023.0479
Special Issue: 肿瘤最新文章合辑; 消化系统疾病最新文章合辑
• Review & Perspectives • Previous Articles Next Articles
Received:
2023-07-21
Revised:
2023-08-27
Published:
2024-02-20
Online:
2023-11-21
Contact:
LI Jie
通讯作者:
李婕
作者简介:
基金资助:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0479
区域 | 发病率 | 死亡率 | ||
---|---|---|---|---|
例数 | ASIR(1/10万) | 例数 | ASMR(1/10万) | |
所有区域 | 364 800 | 17.81 | 318 800 | 15.29 |
城市 | 192 200 | 16.13 | 166 100 | 13.64 |
农村 | 172 600 | 20.07 | 152 700 | 17.52 |
东部地区 | 122 900 | 15.31 | 152 700 | 13.52 |
中部地区 | 122 900 | 18.23 | 152 700 | 15.97 |
西部地区 | 116 100 | 20.85 | 96 200 | 16.98 |
Table 1 Incidence and mortality of primary liver cancer in China
区域 | 发病率 | 死亡率 | ||
---|---|---|---|---|
例数 | ASIR(1/10万) | 例数 | ASMR(1/10万) | |
所有区域 | 364 800 | 17.81 | 318 800 | 15.29 |
城市 | 192 200 | 16.13 | 166 100 | 13.64 |
农村 | 172 600 | 20.07 | 152 700 | 17.52 |
东部地区 | 122 900 | 15.31 | 152 700 | 13.52 |
中部地区 | 122 900 | 18.23 | 152 700 | 15.97 |
西部地区 | 116 100 | 20.85 | 96 200 | 16.98 |
危险因素 | 总人群 | 男性 | 女性 |
---|---|---|---|
HBV感染 | 53.2 | 55.6 | 46.5 |
HCV感染 | 17.0 | 17.4 | 15.9 |
吸烟 | 12.8 | 15.7 | 4.8 |
饮酒 | 7.9 | 10.3 | 1.6 |
DM | 10.4 | 10.9 | 8.8 |
肥胖 | 11.0 | 10.3 | 13.0 |
Table 2 Population attributable fractions of risk factors for primary liver cancer in China
危险因素 | 总人群 | 男性 | 女性 |
---|---|---|---|
HBV感染 | 53.2 | 55.6 | 46.5 |
HCV感染 | 17.0 | 17.4 | 15.9 |
吸烟 | 12.8 | 15.7 | 4.8 |
饮酒 | 7.9 | 10.3 | 1.6 |
DM | 10.4 | 10.9 | 8.8 |
肥胖 | 11.0 | 10.3 | 13.0 |
[1] |
|
[2] |
|
[3] |
|
[4] |
|
[5] |
|
[6] |
|
[7] |
|
[8] |
安澜,曾红梅,郑荣寿,等. 2015年中国肝癌流行情况分析[J]. 中华肿瘤杂志,2019,41(10):721-727. DOI:10.3760/cma.j.issn.0253?3766.2019.10.001.
|
[9] |
曾红梅,曹毛毛,郑荣寿,等. 2000—2014年中国肿瘤登记地区肝癌发病年龄变化趋势分析[J]. 中华预防医学杂志,2018,52(6):573-578. DOI:10.3760/cma.j.issn.0253-9624.2018.06.004.
|
[10] |
|
[11] |
|
[12] |
|
[13] |
|
[14] |
陈万青,崔富强,樊春笋,等. 中国肝癌一级预防专家共识(2018)[J]. 临床肝胆病杂志,2018,34(10):2090-2097.
|
[15] |
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
陈曦阳光,吴君. 乙型肝炎肝硬化并发原发性肝癌相关危险因素Meta分析[J]. 肝脏,2019,24(4):398-404. DOI:10.14000/j.cnki.issn.1008-1704.2019.04.019.
|
[21] |
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
丁惠国,屠红,曲春枫,等. 原发性肝癌的分层筛查与监测指南(2020版)[J]. 临床肝胆病杂志,2021,37(2):286-295.
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
|
[32] |
|
[33] |
|
[34] |
|
[35] |
|
[36] |
|
[37] |
|
[38] |
|
[39] |
|
[40] |
|
[41] |
|
[42] |
|
[43] |
|
[44] |
|
[45] |
|
[46] |
|
[47] |
|
[48] |
|
[49] |
|
[50] |
|
[51] |
|
[52] |
|
[53] |
|
[54] |
|
[55] |
|
[56] |
|
[57] |
|
[58] |
|
[59] |
|
[60] |
|
[61] |
|
[62] |
|
[63] |
|
[64] |
|
[1] | TIAN Chen, LIU Jianing, TIAN Jinhui, GE Long. Living Systematic Reviews: Methods and Processes for Development [J]. Chinese General Practice, 2025, 28(30): 3853-3860. |
[2] | WANG Tingting, TANG Yong, ZHANG Wenke, LI Zhigang. Research Progress on Exercise Intervention of Hyperuricemia [J]. Chinese General Practice, 2025, 28(30): 3841-3846. |
[3] | XU Baichuan, WANG Yan, ZHANG Peng, LI Yiting, LIU Feilai, XIE Yang. Research and Analysis of Screening Tools for Chronic Obstructive Pulmonary Disease Comorbidity Lung Cancer [J]. Chinese General Practice, 2025, 28(30): 3847-3852. |
[4] | ZHOU Sheng, DENG Changsheng, ZOU Guanyang, SONG Jianping. Research Progress on the Pathogenesis of Complications of Malaria in Cardiovascular Diseases [J]. Chinese General Practice, 2025, 28(27): 3466-3472. |
[5] | SHAO Xiaoying, SHAO Jie, ZHU Yan, SHAO Jinling, SHANG Ling, WU Zhenlian, ZHAO Yu, ZHANG Jiacai. Analysis of the Current Status of Iron Deficiency and Factors Affecting Iron Deficiency Anemia among Children Aged 6-36 Months in Guizhou Province [J]. Chinese General Practice, 2025, 28(27): 3368-3374. |
[6] | HUANG Yulin, WANG Haoyun, LI Yanmei, XIAO Xueying. Symptom Clusters in Gastric Cancer Patients Receiving Chemotherapy: a Scoping Review [J]. Chinese General Practice, 2025, 28(26): 3338-3344. |
[7] | LIU Yinyin, SUI Hongping, LI Tingting, JIANG Tongtong, SHI Tieying, XIA Yunlong. Advances in Risk Prediction Models for Cardiotoxicity Associated with Breast Cancer Treatment [J]. Chinese General Practice, 2025, 28(24): 3072-3078. |
[8] | LI Miaoxiu, ZHU Bowen, KONG Lingjun, FANG Min. Progress in Research on Clinical Assessment Tools for Conservative Treatment of Adolescent Idiopathic Scoliosis [J]. Chinese General Practice, 2025, 28(24): 3079-3088. |
[9] | XIAO Yao, WAN Jun. Treatment of Venous Thromboembolism in Special Populations with Direct Oral Anticoagulants [J]. Chinese General Practice, 2025, 28(24): 3066-3071. |
[10] | RUAN Wanbai, LI Junfeng, YIN Yanmei, PENG Lei, ZHU Kexiang. Research Progress of Targeted Therapy and Immunotherapy for Pancreatic Cancer [J]. Chinese General Practice, 2025, 28(23): 2950-2960. |
[11] | ZHOU Lianpeng, LI Weifeng, DONG Xingang, WANG Xiaoyuan. Research Progress on the Role of Copper Homeostasis Regulation Mechanism in Cognition Disorder [J]. Chinese General Practice, 2025, 28(23): 2941-2949. |
[12] | ZHOU Qian, WU Xiaomin, WANG Baohua, YAN Ruohan, YU Miao, WU Jing. Study on Nomogram Prediction Model for Risk of Gastric Cancer [J]. Chinese General Practice, 2025, 28(23): 2870-2877. |
[13] | DONG Haocheng, HAO Xiao, AN Dong, LI Haohan, LI Shuren. Research Progress of Heart Failure with Supra-normal Ejection Fraction [J]. Chinese General Practice, 2025, 28(21): 2692-2696. |
[14] | DU Qiongliang, LIN Bailang, GUO Honghua. Research Progress and Implications of Group Well-child Care [J]. Chinese General Practice, 2025, 28(21): 2672-2678. |
[15] | WEN Yongxia, SUN Hai, CHEN Xiaoju, CAI Wanjing, LI Shuni, GUO Honghua. A Systematic Review of the Assessment Tools for Maternal Psychological Birth Trauma [J]. Chinese General Practice, 2025, 28(20): 2555-2561. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||